News
Mylan Receives Approval for Generic Version of Precose Tablets
Mylan Inc.announced that its subsidiary Mylan Pharmaceuticals Inc. has received final approval from the U.S. Food and Drug Administration (FDA) for its Abbreviated New...
News
Boehringer Ingelheim to Purchase Amgen’s Fremont Facility
Amgen Inc. and Boehringer Ingelheim announced they have signed an agreement under which Boehringer Ingelheim will acquire Amgen's rights in and substantially all assets...
Press Releases
ARIAD Announces Oral Ridaforolimus Achieved Primary Endpoint of Improved Progression-Free Survival in Patients
ARIAD Pharmaceuticals, Inc. announced top-line data showing that ridaforolimus, an investigational oral mTOR inhibitor, met the primary endpoint of improved progression-free survival (PFS) compared...
Packaging & Labelling
Fairfield Group Launched Multi-Scan Solution for Pharmaceutical Packaging Requirements
Leading edge auto ID solutions provider Fairfield Group launched a compliant scan solution that integrates with current and future pharmaceutical industry packaging requirements. ...
Press Releases
Cook Medical’s Ongoing Drug-Eluting Peripheral Stent Trial Shows Consistent Outcomes
An investigational drug-eluting stent (DES) from Cook Medical showed sustained primary patency at two years compared to data collected at one year in the...
News
European Commission Clears Acquisition of Gensyme Corporation by sanofi-aventis
Sanofi-aventis announced that the European Commission has cleared sanofi-aventis' proposed acquistion of Genzyme corporation unconditionally under EU merger control rules. Sanofi-aventis...
Press Releases
Boehringer Ingelheim and Eli Lilly and Company Announce Strategic Alliance to Bring New Diabetes Treatments
Boehringer Ingelheim and Eli Lilly and Company announced a global agreement to jointly develop and commercialize a portfolio of diabetes compounds currently in mid-...
Subscribe
- Never miss a story with notifications
- Gain full access to our premium content
- Browse free from up to 5 devices at once
Must read















